The future of systemic therapy for cutaneous squamous cell carcinoma (CSCC) is rapidly evolving, with research focused on ...

Systemic therapy is often given late due to optimism bias, treatment momentum, and difficulty in end-of-life conversations, leading to increased hospitalizations and ICU admissions. MD Anderson Cancer ...

Andy Blauvelt, MD, MBA, president of Oregon Medical Research Center, discusses the use of systemic therapies vs biologics and why adherence is so important when treating patients with atopic ...

In this systematic review and cohort study, researchers aimed to determine whether receipt of guideline-concordant systemic therapy is associated with OS in iCCA patients.

Prognostic Value of Stromal Tumor-Infiltrating Lymphocytes in Young, Node-Negative, Triple-Negative Breast Cancer Patients Who Did Not Receive (neo)Adjuvant Systemic Therapy This trial randomly ...

Dr. Michael Atkins and Dr. Vernon Sondak highlight the latest updates to the systemic therapy for melanoma recommendations in this newest guideline. The discussion covers neoadjuvant and adjuvant ...

An analysis of more than 250,000 older adults diagnosed with metastatic non-small cell lung cancer showed only about half ...